Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

This study has been completed.
Sponsor:
Collaborators:
i3 Statprobe
Medpace, Inc.
Biomedical Systems
Rules-Based Medicine (RBM)
Information provided by (Responsible Party):
GE Healthcare
ClinicalTrials.gov Identifier:
NCT01252810
First received: December 1, 2010
Last updated: December 18, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)